PHEOCHROMOCYTOMA
Clinical trials for PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug SGI-110 tested for rare tumors, but study stopped early
Disease control TerminatedThis study tested a drug called SGI-110 (guadecitabine) in people aged 12 and older with certain rare cancers that did not respond to other treatments. The cancers included wild-type GIST (a stomach or intestinal tumor), pheochromocytoma/paraganglioma (adrenal or nerve tumors), a…
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental vaccine tackles rare adrenal cancers
Disease control TerminatedThis study tested a new therapeutic vaccine (EO2401) combined with immune checkpoint blockers in 70 people with advanced adrenal cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the vaccine could help the immune system fight t…
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 13, 2026 16:00 UTC